Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Active, not recruitingPhase 3 评价疏风止痛胶囊预防偏头痛发作的有效性和安全性随机、双盲单模拟、安慰剂平行对照的多中心Ⅲ期临床试验
[Translation] A randomized, double-blind, single-dummy, placebo-controlled, multicenter phase III clinical trial to evaluate the efficacy and safety of Shufengzhitong Capsule in preventing migraine attacks
进一步评价疏风止痛胶囊预防偏头痛(寒凝血瘀挟风证)发作的有效性和安全性
[Translation] To further evaluate the effectiveness and safety of Shufeng Zhitong Capsule in preventing migraine (cold stagnation, blood stasis and wind syndrome)
疏风止痛胶囊预防偏头痛发作其有效性和安全性的分层区组随机、双盲、安慰剂、平行对照、多中心Ⅲ期临床试验
[Translation] A stratified block randomized, double-blind, placebo-controlled, parallel-controlled, multicenter phase III clinical trial on the efficacy and safety of Shufengzhitong capsule in preventing migraine attacks
进一步评价疏风止痛胶囊预防偏头痛(寒凝血瘀挟风证)发作的有效性和安全性。
[Translation] To further evaluate the effectiveness and safety of Shufeng Zhitong Capsule in preventing migraine (cold stagnation, blood stasis and wind syndrome).
100 Clinical Results associated with Beijing Boshili Medicine Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Boshili Medicine Technology Co., Ltd.
100 Deals associated with Beijing Boshili Medicine Technology Co., Ltd.
100 Translational Medicine associated with Beijing Boshili Medicine Technology Co., Ltd.